Vabysmo 6 MG/0.05 ML vial 0.05ML
Ended Awarded
- Contract number
- SPE2DB25FQAJV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,917
Award facts
- Contract value 100% obligated
- $2,916.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Vabysmo 6 mg/0.05 mL vials. The contract, valued at $2,916.80 with a firm fixed-price structure, is scheduled for completion by October 9, 2025, and carries no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial engagement with the DLA through its broader Indefinite Delivery Contract vehicle under the SPE2DB program, which has a potential value of approximately $500 million through November 2026.
As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages this IDC to fulfill firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities nationwide. The Vabysmo delivery represents the company's ongoing role in providing specialty pharmaceutical products, including biologics and injectable medications, to Department of Defense healthcare sites. DMS Pharmaceutical Group's consistent contract performance with the DLA, combined with its woman-owned small business status and comprehensive pharmaceutical distribution capabilities, has positioned the company as a reliable vendor for meeting the pharmaceutical supply needs of federal military health systems.
Quick answers
Who was awarded contract SPE2DB25FQAJV?
SPE2DB25FQAJV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FQAJV worth?
The government has obligated $2,917 on SPE2DB25FQAJV.
Is contract SPE2DB25FQAJV an order under another contract?
Yes. SPE2DB25FQAJV is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAJV competed?
The extent of competition for SPE2DB25FQAJV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award